Rigel Pharmaceuticals
RIGL
#6842
Rank
C$0.63 B
Marketcap
$36.30
Share price
3.99%
Change (1 day)
155.76%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): -C$8.92 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are C$0.13 Billion. In 2023 the company made an earning of -C$25.4 Million, an increase over its 2022 earnings that were of -C$76.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$8.92 Million-64.91%
2023 -C$25.4 Million-66.79%
2022 -C$76.48 Million340.73%
2021 -C$17.36 Million-56.15%
2020 -C$39.58 Million-57.34%
2019 -C$92.78 Million-7.66%
2018 -C$0.11 Billion-9.47%
2017 -C$0.12 Billion24.46%
2016 -C$89.17 Million23.63%
2015 -C$72.13 Million-43.29%
2014 -C$0.13 Billion2.5%
2013 -C$0.13 Billion
2010 C$52.76 M-133.97%
2009 -C$0.16 Billion-18.49%
2008 -C$0.2 Billion71.91%
2007 -C$0.12 Billion84.74%
2006 -C$60.01 Million-10.17%
2005 -C$66.8 Million-15.73%
2004 -C$79.27 Million39.29%
2003 -C$56.91 Million10.3%
2002 -C$51.6 Million48.3%
2001 -C$34.8 Million-2.13%
2000 -C$35.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.19 Billion 1,902.15%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.29 Billion 3,065.12%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.10 B-144,236.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$6.52 B-71,830.80%๐Ÿ‡บ๐Ÿ‡ธ USA